In this study, although we think that further investigation is necessary, and suggest that patients older than 70 years of age who have been administered GLP-1-RAs need earlier attention to address GERD-like symptoms than younger patients. The gene discussed is GLP1R; the disease is gastroesophageal reflux disease.